Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

Sector

Healthcare Facilities & Services

More about the company

07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half

Market Cap	48.44M 55.79M 45.17M 41.49M 78.47M 5.31B 79.33M 532M 208M 2.65B 210M 205M 8.79B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	48.57M 55.93M 45.28M 41.6M 78.67M 5.32B 79.54M 534M 209M 2.66B 210M 205M 8.81B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

07-29	EQT to sell Quantios to Vista Equity Partners	FW
07-15	Klea Holding targets improved profitability in the second half
06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
04-01	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT

07-15	Klea : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	PU
07-15	Klea Holding : Smart Salem records a strong rebound in activity in June 2026, confirms solid profitability and favourable outlook	AT
06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT

07-27	Klea Holding : Déclaration des transactions sur actions propres
07-20	Klea Holding : Déclaration des transactions sur actions propres
07-15	Klea Holding vise une amélioration de sa rentabilité au second semestre
07-15	Klea Holding : Smart Salem enregistre un puissant rebond de son activité en juin 2026, confirme sa solide rentabilité et ses perspectives favorables
07-13	Klea Holding : Déclaration des transactions sur actions propres

VISD GP Stock Swiss Exchange

Stocks

OXVMG

FR0011067669

Healthcare Facilities & Services

Valuation: VISD GP

Latest news : VISD GP

Analysts' recommendations: VISD GP

Press Releases: VISD GP

News in other languages: VISD GP

Managers and Directors: VISD GP

Other Healthcare Facilities & Services

Financials

Company Profile

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	22/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	01/04/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	01/04/2022
Paul Amsellem BRD	Director/Board Member	51	14/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CVS HEALTH CORPORATION	-1.34%	-4.74%	+69.50%	+42.89%	134B
HCA HEALTHCARE, INC.	-1.67%	-4.41%	+10.06%	+48.77%	88.03B
FRESENIUS SE & CO. KGAA	-0.92%	+0.14%	+6.92%	+58.15%	29.01B
QUEST DIAGNOSTICS INCORPORATED	+0.90%	-0.75%	+35.79%	+72.62%	25.6B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.38%	+3.15%	-8.12%	-16.06%	22.18B
TENET HEALTHCARE CORPORATION	+1.47%	-3.50%	+57.35%	+240.29%	20.13B
DAVITA INC.	-0.58%	-3.33%	+65.92%	+112.75%	15B
REDE D'OR SÃO LUIZ S.A.	+0.82%	+0.09%	+3.46%	-1.55%	14.73B
FRESENIUS MEDICAL CARE AG	-7.58%	-4.18%	-4.27%	-11.86%	13.68B
Average	-0.89%	+1.33%	+26.29%	+60.67%	40.31B
Weighted average by Cap.	-1.05%	+0.98%	+36.66%	+54.01%

	2024	2025
Net sales	17.26M 19.88M 16.09M 14.78M 27.96M 1.89B 28.27M 190M 74.17M 945M 74.65M 73.01M 3.13B	22.17M 25.53M 20.67M 18.99M 35.91M 2.43B 36.3M 244M 95.25M 1.21B 95.87M 93.76M 4.02B
Net income	1.4M 1.62M 1.31M 1.2M 2.28M 154M 2.3M 15.44M 6.04M 76.94M 6.08M 5.94M 255M	2.28M 2.63M 2.13M 1.95M 3.69M 250M 3.74M 25.07M 9.8M 125M 9.87M 9.65M 414M
Net Debt	2.58M 2.97M 2.4M 2.21M 4.17M 282M 4.22M 28.31M 11.07M 141M 11.14M 10.89M 467M	125K 144K 117K 107K 202K 13.69M 205K 1.37M 537K 6.85M 541K 529K 22.68M

End-of-day quote Swiss Exchange Other stock markets
- ^EUR	-